FOLLIGON PMSG 200 IU/ML LYOPHILISATE AND SOLVENT FOR SOLUTION FOR INJECTION

Quốc gia: Ai-len

Ngôn ngữ: Tiếng Anh

Nguồn: HPRA (Health Products Regulatory Authority)

Thành phần hoạt chất:

GONADOTROPHIN

Sẵn có từ:

Intervet Ireland Limited

Mã ATC:

QG03GA03

INN (Tên quốc tế):

GONADOTROPHIN

Liều dùng:

1000 International Unit

Dạng dược phẩm:

Pdr+Solv for Susp for Inj

Loại thuốc theo toa:

POM

Nhóm trị liệu:

Bovine, Ovine, Porcine

Khu trị liệu:

Serum gonadotrophin

Chỉ dẫn điều trị:

Hormone

Tình trạng ủy quyền:

Authorised

Ngày ủy quyền:

1998-09-19

Đặc tính sản phẩm

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Folligon PMSG 200 IU/ml lyophilisate and solvent for solution for
injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
After reconstitution, each ml contains:
ACTIVE SUBSTANCE:
Serum gonadotrophin
200 IU
EXCIPIENTS:
For the full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Lyophilisate and solvent for solution for injection.
Lyophilisate: White powder.
Solvent: Clear, colourless.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, sheep and pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
To stimulate the development of the ovarian follicle in the female and
has spermatogenic activity in the male by its
effect on the seminiferous tubules.
Folligon PMSG is a complex glycoprotein obtained from the serum of
pregnant mares.
This substance is capable of
supplementing and being substituted for
follicle stimulating gonadotrophin of
the anterior
pituitary gland in both
female and male animals.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_1_
_/_
_0_
_3_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_6_
_0_
_2_
_0_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Where the possibility of multiple ovulations has not been excluded by
clinical examination following administration of
Folligon PMSG to uniparous species (unless to ind